# US 2025/0144252 A1 · Carbon nanoparticle suspension injection-fe, preparation method, application and use method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0144252 A1
- Document ID: US20250144252A1
- Status: Published application
- Kind: A1
- Application number: 18/970,315
- Filed: 2024-12-05
- Published: 2025-05-08
- Earliest claimed: 2023-03-31
- Assignees: Sichuan Enray Pharmaceutical Technology Co., Ltd.
- Applicants: Sichuan Enray Pharmaceutical Technology Co., LTD.
- Inventors: Xiaohai Tang; Kexin Tang; Yuanfang Huang; Cheng Zeng
- Web page: https://patentgrep.com/patent/US20250144252A1

## CPC

- A61K 49/1806: {Suspensions, emulsions, colloids, dispersions}
- A61K 49/1818: {particles, e.g. uncoated or non-functionalised microparticles or nanoparticles}
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 9/5115: {Inorganic compounds}
- A61K 47/12: Carboxylic acids; Salts or anhydrides thereof
- A61K 47/34: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence)
- A61K 49/08: characterised by the carrier
- A61P 35/00: Antineoplastic agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Carbon nanoparticle suspension injection-Fe, a preparation method, an application and a use method. The carbon nanoparticle suspension injection-Fe includes carbon nanoparticle suspension injection and ferrous sulfate, where a concentration of the carbon nanoparticle suspension injection is 20-100 mg/mL, a concentration of ferrous ions in the carbon nanoparticle suspension injection-Fe is 0.5-60 mg/mL, and a particle size of carbon nanoparticles in the carbon nanoparticle suspension injection-Fe is 90-250 nm, and a pH value is 2.8-6.0. The carbon nanoparticle suspension injection-Fe serves as a developing agent after being injected into a tumor to show distribution of the carbon nanoparticle suspension injection-Fe and retention in the tumor on a magnetic resonance image.

## Claims

### Claim 1

Carbon nanoparticle suspension injection-Fe, comprising carbon nanoparticle suspension injection and ferrous sulfate, wherein a concentration of the carbon nanoparticle suspension injection is 20-100 mg/mL, and a concentration of ferrous ions in the carbon nanoparticle suspension injection-Fe is 0.5-60 mg/mL.

### Claim 2 (depends on 1)

The carbon nanoparticle suspension injection-Fe according to claim 1, wherein the concentration of the carbon nanoparticle suspension injection is 50 mg/mL, and the concentration of the ferrous ions is 15-60 mg/mL.

### Claim 3 (depends on 1)

The carbon nanoparticle suspension injection-Fe according to claim 1, wherein a particle size of carbon nanoparticles in the carbon nanoparticle suspension injection-Fe is 90-250 nm, and a pH value is 2.8-6.0.

### Claim 4 (depends on 1)

The carbon nanoparticle suspension injection-Fe according to claim 1, wherein each 1000 mL of the carbon nanoparticle suspension injection comprises: 20-100 g of carbon nanoparticles, 17-30 g of poloxamer, 2-4 g of sodium citrate, 8-10 g of sodium chloride, 0.05-0.5 g of dimethicone, and the balance water for injection.

### Claim 5 (depends on 2)

The carbon nanoparticle suspension injection-Fe according to claim 2, wherein each 1000 mL of the carbon nanoparticle suspension injection comprises: 50 g of carbon nanoparticles, 20 g of poloxamer, 0.2 g of dimethicone, 3 g of sodium citrate, 9 g of sodium chloride, and the balance water for injection.

### Claim 6 (depends on 1)

A preparation method for carbon nanoparticle suspension injection-Fe, used for preparing the carbon nanoparticle suspension injection-Fe according to claim 1, comprising:
preparing carbon nanoparticles;
preparing each 20 mL of carbon nanoparticle suspension injection: selecting 400-2000 mg of carbon nanoparticles, 340-600 mg of poloxamer, 1-10 mg of dimethicone, 40-80 mg of sodium citrate, 160-200 mg of sodium chloride and the balance water for injection, performing homogenization for 5-10 minutes, and performing fine homogenization multiple times to prepare 20 mL of carbon nanoparticle suspension injection;
preparing each part of ferrous sulfate: dissolving 1490 mg of ferrous sulfate heptahydrate in 20 ml of water for injection, adjusting a pH value of the solution to 2.8, performing packaging, performing freeze-drying, backwashing nitrogen, and pressing lips, thereby obtaining ferrous sulfate for injection; and
sucking the carbon nanoparticle suspension injection, adding the carbon nanoparticle suspension injection into the ferrous sulfate for injection, and performing uniform mixing to obtain the carbon nanoparticle suspension injection-Fe.

### Claim 7 (depends on 6)

The preparation method according to claim 6, wherein the preparing carbon nanoparticles comprises:
washing carbon nanoparticles with ethyl acetate, and then, performing filtering and drying;
washing the carbon nanoparticles with nitric acid, then, washing the carbon nanoparticles with water until a washing solution is neutral, and performing filtering and drying; and
washing the carbon nanoparticles with sodium hydroxide, then, washing the carbon nanoparticles with water until a washing solution is neutral, and performing filtering and drying.

### Claim 8 (depends on 6)

The preparation method according to claim 6, wherein the sucking the carbon nanoparticle suspension injection, adding the carbon nanoparticle suspension injection into the ferrous sulfate for injection comprises:
in the case that the concentration of the ferrous ions is 60 mg/mL, taking 0.5 mL of carbon nanoparticle suspension injection, injecting same into a ferrous sulfate bottle under the condition of isolating air to be mixed, shaking same well, and shaking the mixture well after mixing to obtain the carbon nanoparticle suspension injection-Fe;
in the case that the concentration of the ferrous ions is 30 mg/mL, taking 1 mL of carbon nanoparticle suspension injection, injecting same into a ferrous sulfate bottle under the condition of isolating air to be mixed, shaking same well, and shaking the mixture well after mixing to obtain the carbon nanoparticle suspension injection-Fe;
in the case that the concentration of the ferrous ions is 15 mg/mL, taking 2 mL of carbon nanoparticle suspension injection, injecting same into a ferrous sulfate bottle under the condition of isolating air to be mixed, shaking same well, and shaking the mixture well after mixing to obtain the carbon nanoparticle suspension injection-Fe;
in the case that the concentration of the ferrous ions is 7.5 mg/mL, taking 4 mL of carbon nanoparticle suspension injection, injecting same into a ferrous sulfate bottle under the condition of isolating air to be mixed, shaking same well, and shaking the mixture well after mixing to obtain the carbon nanoparticle suspension injection-Fe; and
in the case that the concentration of the ferrous ions is 3.75 mg/mL, taking 8 mL of carbon nanoparticle suspension injection, injecting same into a ferrous sulfate bottle under the condition of isolating air to be mixed, shaking same well, and shaking the mixture well after mixing to obtain the carbon nanoparticle suspension injection-Fe.

### Claim 9 (depends on 1)

An application of carbon nanoparticle suspension injection-Fe in magnetic resonance imaging development, in which the carbon nanoparticle suspension injection-Fe according to claim 1, wherein
the carbon nanoparticle suspension injection-Fe serves as a developing agent after being injected into a tumor to show a distribution area, a distribution amount and retention time of the carbon nanoparticle suspension injection-Fe on the surface of the tumor and/or in the tumor in a magnetic resonance image.

### Claim 10 (depends on 1)

A use method of carbon nanoparticle suspension injection-Fe in magnetic resonance imaging development, employing the carbon nanoparticle suspension injection-Fe according to claim 1, and comprising:
determining a location and a size of a tumor for the first time through magnetic resonance imaging;
injecting the carbon nanoparticle suspension injection-Fe into the determined location of the tumor for the first time;
determining distribution of the carbon nanoparticle suspension injection-Fe in the tumor through magnetic resonance imaging by taking the carbon nanoparticle suspension injection-Fe as a developing agent; and
injecting the carbon nanoparticle suspension injection-Fe again at the tumor site where no or less the carbon nanoparticle suspension injection-Fe is distributed.

### Claim 11 (depends on 10)

The use method according to claim 10, further comprising:
before each injection of the carbon nanoparticle suspension injection-Fe, determining the size and/or the location of the tumor and the distribution of the carbon nanoparticle suspension injection-Fe in the tumor through magnetic resonance imaging by taking the carbon nanoparticle suspension injection-Fe as the developing agent.

### Claim 12 (depends on 10)

The use method according to claim 10, further comprising:
after each injection of the carbon nanoparticle suspension injection-Fe, determining the distribution of the carbon nanoparticle suspension injection-Fe in the tumor through magnetic resonance imaging by taking the carbon nanoparticle suspension injection-Fe as the developing agent.

### Claim 13 (depends on 10)

The use method according to claim 10, wherein the distribution of the carbon nanoparticle suspension injection-Fe in the tumor comprises: a distribution area, a distribution amount and retention time of the carbon nanoparticle suspension injection-Fe on the surface of the tumor and/or in the tumor at different time points after injection.

### Claim 14 (depends on 6)

The method of claim 6, wherein the concentration of the carbon nanoparticle suspension injection is 50 mg/mL, and the concentration of the ferrous ions is 15-60 mg/mL.

### Claim 15 (depends on 6)

The method of claim 6, wherein a particle size of carbon nanoparticles in the carbon nanoparticle suspension injection-Fe is 90-250 nm, and a pH value is 2.8-6.0.

### Claim 16 (depends on 6)

The method of claim 6, wherein each 1000 mL of the carbon nanoparticle suspension injection comprises: 20-100 g of carbon nanoparticles, 17-30 g of poloxamer, 2-4 g of sodium citrate, 8-10 g of sodium chloride, 0.05-0.5 g of dimethicone, and the balance water for injection.

### Claim 17 (depends on 14)

The method of claim 14, wherein each 1000 mL of the carbon nanoparticle suspension injection comprises: 50 g of carbon nanoparticles, 20 g of poloxamer, 0.2 g of dimethicone, 3 g of sodium citrate, 9 g of sodium chloride, and the balance water for injection.

### Claim 18 (depends on 9)

The application of claim 9, wherein the concentration of the carbon nanoparticle suspension injection is 50 mg/mL, and the concentration of the ferrous ions is 15-60 mg/mL.

### Claim 19 (depends on 9)

The application of claim 9, wherein a particle size of carbon nanoparticles in the carbon nanoparticle suspension injection-Fe is 90-250 nm, and a pH value is 2.8-6.0.

### Claim 20 (depends on 9)

The application of claim 9, wherein each 1000 mL of the carbon nanoparticle suspension injection comprises: 20-100 g of carbon nanoparticles, 17-30 g of poloxamer, 2-4 g of sodium citrate, 8-10 g of sodium chloride, 0.05-0.5 g of dimethicone, and the balance water for injection.
